- 2x
- 1.75x
- 1.5x
- 1.25x
- 1x, selected
- 0.75x
- 0.5x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
This education was originally presented at the 32nd Annual Selected Topics in Internal Medicine 2020 in Kapalua, Hawaii. The 2021 Conference will be conducted on January 25 – 29, 2021, via livestream.
Published:
0 Comments
Family Medicine & Primary Care Specialty
Internal Medicine Specialty
Psychiatry & Psychology Specialty
Addiction Subspecialty

Mayo Clinic
Download our mobile app
Follow Us
Made with LOVE in Los Angeles | © Copyright 2025
Earn CME Credits
Upgrade to a Premium Account to start earning CME credits.
Past Notes
Yeah, one mL JUUL pod
contains 56 milligrams.
You can extract about 20 milligrams
from a pack of cigarettes.
Probably more than that...
Hi, my name is Taylor Hayes, I'm a
professor of medicine and in
the general internal medicine
division at Mayo Clinic.
I'm also the director of the
Nicotine Dependence Center at Mayo
Clinic in Rochester, Minnesota.
So today we're gonna talk about
electronic cigarettes, a topic
that a lot of clinicians have some
confusion about.
What we're going to do today is look
at some of the trends in the use
of e-cigarettes and look
at some of the concerns that
have come from the use of
e-cigarettes, especially recently in
the news.
And finally, look at some
of the evidence for and against the
use of e-cigarettes to help people
stop smoking traditional tobacco
cigarettes.
So the use of tobacco
cigarettes and the declining
prevalence in the United States is
really probably one of the greatest
public health victories in the last
century.
We've seen a steady decline in the
use of traditional tobacco
cigarettes in adults from somewhere
around 15% of men
in 1965.
And now among all
adults, the prevalence is more like
14-15% in the United
States.
The bad news is that we still have
about 15% of adults smoking,
and that represents about
35-40 million people because
of the growth in the population
of the US. So we still have a lot of
work to do.
We've also seen an
uptake of electronic cigarettes
in adults.
Certainly not to the degree that
we've seen in youth, which I'll talk
about in a moment.
In adults, most of the electronic
cigarette use has been in people
under age 50 and in fact, most of
it's been under age 35.
And for most
adult smokers who
use e-cigarettes, it's dual use.
Although they may be trying to quit
smoking, they continue to use
tobacco cigarettes and have reduced
their use of tobacco and are
at the same time using electronic
cigarettes.
That's not what we've seen in
kids. However, what we've seen in
youth, especially in middle school
and high school students, is
a really worrisome increase
in the use of electronic cigarettes.
Now, this came at the time that we
were seeing another good news story.
Tobacco use among high school and
middle aged students had declined,
remarkably over the last decade.
In
2016-2017, we saw a decline in
e-cigarette use as well.
And we thought maybe we breathed a
sigh of relief. You know, that the
uptake of electronic cigarettes that
we'd been seeing in youth seems
to be waning. But then in 2018,
we saw almost an
80% increase in the prevalence
of cigarette use in high school
students.
And in 2019, we now have
1:4 12th graders currently
using e-cigarettes and 1:10
middle schoolers.
And those numbers seem to be rising
all the time.
What fueled this increase?
Well, probably a number of things.
But one was the marketing
done by this unregulated industry,
the marketing of electronic
cigarettes to kids that took the
form of a lot of common consumer
products that kids like:
candy, gum,
whipped cream, apple juice.
And some of the
pictures you've probably seen in the
news have shown some of the labeling
that these companies have used
to make their labels for the
electronic cigarette liquids
look like candy and whipped
cream and other consumer products.
The other thing that has fueled
this has been the
marketing of a product called JUUL,
in particular, this
is a company
that marketed an electronic
cigarette product that looks like a
an external drive from a computer.
So it didn't look at all
like a cigarette.
And so parents and students and
adults didn't know what these were
and kids took them up in remarkable
numbers.
So with that in mind
as background, we are going to talk
now a little bit about the products
themselves, the electronic cigarette
devices.
The thing to remember about all of
the devices, no matter what kind it
is, is that they have some common
features.
The common features are
you need a heating element that
usually is a metal coil,
and that heating element needs a
power source.
So there's a battery.
And then the other component is
electronic liquids.
These liquids contain typically
nicotine. But as you know from the
news, that they can contain other
drugs as well, particularly
marijuana extracts, or THC.
But those are the common
components.
A heating element.
A coil.
A power source or battery.
And electronic cigarette
juice or e-liquid,
which usually contains nicotine and
other chemicals, which I'll describe
in a minute. And these products have
changed remarkably over the last
10 years.
The initial products
looked like cigarettes and we call
them cigalikes.
They were typically disposable.
They were closed systems.
You use them a few times and threw
them away once the liquid was used
up.
The newest models of electronic
cigarettes look nothing like
cigarettes.
They look like boxes or
vape pens.
Sometimes they're called and they
contain components that are
interchangeable
amongst the different
brands. So they all
still contain a power source
and a coil and e-liquid.
But now they've been modified to the
point that you can use different
liquids. They have refillable models
and the vessel that contains the
liquid can be refilled with
different liquids.
You can also interchange all
of the parts.
You can interchange the power
source.
You can use different coils
in these and you can
use different mouthpieces.
They've become very sophisticated as
well. You can actually modify
the voltage and amperage with which
they deliver the e-liquid.
Now, the key
to all of these
products, the key to all of these
devices are two things.
And these drive the delivery of the
chemicals from the aerosol it's
formed, so one is the coil,
the metal coil that's used to heat
e-liquid and aerosolize it is
different in different products.
And now we are able
to get these coils to very
high temperatures with the power
sources that are being used.
The other key is the pharmacology
of the electronic cigarette liquids
that are being used.
We know from chemistry that the
tobacco industry developed going
back into the early 1960s
that the more basic
the aerosol or
the smoke from a cigarette, the
better the delivery of nicotine.
And that's because
as the smoke
or vapor becomes more basic
from a traditional pack tobacco
cigarette, the more unprotonated
nicotine you'll find.
And it is the freebase nicotine
that is absorbed well across
biological membranes.
The tobacco industry actually added
ammonia to tobacco to get a more
basic or alkaline
pH.
But what we know is that at high
concentrations alkaline pH
causes a lot of adverse reactions
and mostly nausea.
People gag when they are exposed
to high alkaline pHs.
And so what the electronic
cigarette industry has come
to learn is that actually
creating more acidic liquids
that are salts or
nicotine salts has become a more
effective way to deliver high
concentrations of nicotine
in the e-liquids.
These are salts that usually
use benzoic acid as the diluent
and the pHs are more acidic.
These can contain high
concentrations of nicotine without
causing nausea when
they're inhaled.
We also see that with
these high concentrations of
nicotine in the e-liquid solutions
and the newer coils, higher power
in the batteries that we are
now seeing the delivery of
nicotine as
monitored by blood levels
comparable to what we see with
tobacco cigarettes.
Also, the profile
of uptake is looking more like
tobacco cigarettes.
So with a tobacco cigarette, you can
get nicotine levels that are 10
to 20 nanograms per mL in the blood
within just a few seconds of
inhaling.
And now with electronic cigarettes,
we're seeing a similar profile
within a minute or so of the
inhalation.
You can see high levels of nicotine
in the blood.
Nicotine salt, delivery systems,
typically in the pod systems, but
also in some of the refillable is
now contain as much nicotine as one
to two or more packs of cigarettes
per day.
I know people have heard that the
JUUL, which I mentioned before, is
fueling the youth uptake of
cigarette use contains
as much as "a pack of cigarettes".
In fact, the JUUL pods contain
about one and a half to two
and a half package
equivalents of nicotine.
So if you smoke a pod a day
of JUUL, a
high school student doing that is
consuming about the same amount of
nicotine as he or she would get from
a pack and a half to two packs of
cigarettes in that day.
That means they're becoming
nicotine dependent very quickly.
The other part of the nicotine
or rather the e-cigarette liquids
that you need to understand is that
although nicotine is the thing
that causes the
addiction, that dependence and
delivering high levels of nicotine
quickly is important to create that
dependence.
There are other components of
electronic cigarette liquids.
These are typically carriers,
vegetable glycerin and propylene
glycol.
Now, these are generally recognized
as safe either for oral consumption
in foods or as a topical
applicant. So they're used in
gels and creams on skin.
They're used as sweeteners
or diluent in food
that we consume.
And they're safe in that way.
They're used also as the vehicles
for electronic cigarette liquid
propylene glycol is used
and usually mixed with vegetable
glycerin because the vegetable
glycerin is a bit thicker and
you need a thickening agent in most
of these e-liquids,
so that they don't leak out of the
vessel.
When these things are heated to very
high levels, they no longer
stay as vegetable glisten or
propylene glycol.
But they are inhaled as carbonyl
compounds among these formaldehyde
and acetaldehyde.
And now at the high temperatures we
see with the coils in the modern
e-cigarettes, you're getting
significant levels of formaldehyde,
acetaldehyde inhaled.
And we know that these compounds,
among other carbonyls, are
carcinogens.
And so we don't know what the long
term impact will be of dail, the
inhalation of high levels of these
chemicals.
Finally, let's
talk a little bit about some of the
health impacts of cigarette use.
Now, frankly, we hadn't seen a lot
of adverse health impacts of
cigarette use up until
this past year.
And this past year, we saw
a remarkable rise in
what has been called EVALI (EVALI),
or the electronic-cigarette
and vapor associated
lung injury.
This epidemic started
in about the second quarter of 2019
and now seems to have peaked
somewhere around the third quarter
of 2019. Early
in 2020, we're seeing
many fewer cases and
that's probably because of the
education that went out through the
news and through other public health
channels, as well as through
magazines and newspapers.
Now, I don't want to leave you with
the idea that EVALI is caused from
nicotine containing e-cigarettes,
although it may be a small portion
of the cause of a EVALI.
We think now that most
of the lung injury was caused from
vaping solutions that contained
THC.
That is the
active ingredient of marijuana that
causes the high and
that it seems that many of the
e-liquids that were being used that
contain THC were being cut with
not propylene glycol or vegetable
glycerin, but with vitamin E
acetate.
This is a thickening agent
and a diluent that was being used
in these unregulated
e-cigarettes liquids.
And we think that the chemical
changes that occurred with heating
of the vitamin E acetate probably
led to some of the lung injury.
That's a best guess right now.
But what is clear is that
inhalation of many
e-liquids may cause lung
injury, perhaps not
to the degree that we saw with EVALI
where many people got very ill very
quickly and we had many deaths.
But over the long
term, we think that inhalation of
some of these chemicals will cause
lung injury.
What do we do with all this
information?
I mean, the promise of e-cigarettes
really was that perhaps
it would be a way for us to finally
get adults to stop smoking
tobacco cigarettes, where we know
over 60% of people who use
them regularly will die from a
tobacco caused disease.
Maybe we could use e-cigarettes to
get them to switch.
And ultimately, we could have
a society where no one used tobacco
any longer.
That would be an approach called
harm reduction.
Now, we're familiar with harm
reduction in many other forms.
We use seatbelts in cars not
because it eliminates all the harm
of driving. We use
bicycle helmets to prevent head
injuries. But it doesn't prevent all
of them. And we, even in health
care, have
safe needle programs so that
injection drug users
can reduce the harm of serious
infectious diseases from using
their injection drugs.
Now, none of these approaches
eliminates the harm of these
behaviors, but they reduce it.
Similarly, we thought, well, maybe
e-cigarettes would be a way to
reduce harm from tobacco use if we
could get people to switch.
What we don't know is really where
does e-cigarettes fall
on that continuum of risk where we
know cigarettes are most harmful.
And complete cessation
of all tobacco product use,
including e-cigarettes, is the least
harmful.
Where do e-cigarettes fall?
We thought they were probably
ultimately relatively safe.
There had been a publication from
Public Health England in 2018 that
said, "They
were 95% safer
than than regular cigarettes".
It's unclear whether or not that's
true, especially in light of what we
saw with the EVALI that occurred
in the past year.
What is clear is
that they are safer, but
not necessarily safe.
And so when we advise
patients, we try to advise them
based on what we know is supported
by best evidence,
what we know from all of the
evidence so far with electronic
cigarettes is that there is
insufficient evidence to recommend
them as a smoking cessation
approach.
So for clinicians,
our advice and the nicotine
dependence center is to say
if someone is committed to quitting
smoking cigarettes, we advise
the use of what is known to be
effective and safe.
That is the combined approach
of behavioral therapy or
counselling, plus approved
medications.
And there are seven approved
pharmacotherapies for smoking
cessation in the US.
We don't advise the
use of electronic cigarettes.
There is only one randomized trial
that is compared directly
e-cigarettes and nicotine
replacement therapy.
And that was done in England, it was
published in 2019.
It did show that electronic
cigarettes seem to be equivalent
or perhaps even slightly better
than the nicotine
replacement therapy nicotine patch
plus gum.
This is only one study.
It hasn't been replicated by anyone.
And so our advice follows
the U.S. Preventive Services Task
Force in that behavioral therapy
plus pharmacotherapy that's approved
is the best way for people to quit
if you have someone who simply
will not quit in any other way, you
may say to them, well, perhaps
e-cigarettes is the best way to do
that.
If you make that recommendation,
do that knowing that we don't know
the ultimate safety of e-cigarettes
and that the only way that they can
have the health benefits
of stopping smoking is to quit
completely using tobacco cigarettes
and switch completely to
a known brand of electronic
cigarettes that at least we think
complies with some good
manufacturing process.
Most of our professional
societies have
said that they don't recommend
e-cigarettes, although some have
said if you have to
advise a switch, but the switch
needs to be complete for adults
and we'd never advise pregnant women
or children to use e-cigarettes.
The reason
we take this approach is really the
precautionary principle.
And that principle is this.
The introduction of a new product or
process whose ultimate effects are
disputed or unknown
should be resisted.
And we as clinicians,
although we're very interested in
the public health, our
responsibility is to the patient
who's in front of us.
We are a fiduciary to that patient.
So our advice to the patient
is based on best evidence.
And our best evidence today says
behavioral therapy plus nicotine
replacement therapy or other
approved medication is the best
and safest approach.
So to summarize,
we we reviewed some of the
epidemiology and the remarkable
rise of cigarette use in
youth especially.
We looked at some of the pros and
cons of using e-cigarettes for
smoking cessation.
And we talked about
some of the health impacts of these
new devices that now are changing
very quickly.
There's still a promise that
e-cigarettes might help us in the
future, but we're going to have to
work through this current issue of
the diseases and health negative
health impacts that e-cigarettes
have had on lung injury
and come up with new technologies
that are proven to be safe for our
patients before we can recommend
them.
Not Available
This feature is not available with your current plan. Please ask your administrator to contact GIBLIB to potentially add this feature.